FDA Approves AZITHROMYCIN — Eugia US LLC
Eugia US LLC received FDA approval for the intravenous generic version of azithromycin (ANDA 203294). This addition is expected to enhance generic market availability and improve access to the antibiotic.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed